Schiffman A, Cheng Z, Ourthiague D, Hoffmann A
bioRxiv. 2025; .
PMID: 39975349
PMC: 11838565.
DOI: 10.1101/2025.02.04.636520.
Leib L, Juli J, Jurida L, Mayr-Buro C, Priester J, Weiser H
EMBO Rep. 2025; 26(4):1144-1183.
PMID: 39753783
PMC: 11850942.
DOI: 10.1038/s44319-024-00339-8.
Pulupa J, McArthur N, Stathi O, Wang M, Zazhytska M, Pirozzolo I
Res Sq. 2024; .
PMID: 39678350
PMC: 11643329.
DOI: 10.21203/rs.3.rs-5448201/v1.
Zhang C, He Y, Sun X, Wei W, Liu Y, Rao Y
Acta Mater Med. 2024; 2(4):409-429.
PMID: 39221114
PMC: 11364368.
DOI: 10.15212/amm-2023-0039.
Inge M, Miller R, Hook H, Bray D, Keenan J, Zhao R
Nucleic Acids Res. 2024; 52(17):10276-10296.
PMID: 39166482
PMC: 11417405.
DOI: 10.1093/nar/gkae706.
HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis.
Guo J, He K, Yuan J, An W, Yin W, Li Q
Int J Biol Sci. 2024; 20(7):2640-2657.
PMID: 38725843
PMC: 11077367.
DOI: 10.7150/ijbs.95595.
Rapid profiling of transcription factor-cofactor interaction networks reveals principles of epigenetic regulation.
Inge M, Miller R, Hook H, Bray D, Keenan J, Zhao R
bioRxiv. 2024; .
PMID: 38617258
PMC: 11014505.
DOI: 10.1101/2024.04.05.588333.
Enhancer selectivity in space and time: from enhancer-promoter interactions to promoter activation.
Yang J, Hansen A
Nat Rev Mol Cell Biol. 2024; 25(7):574-591.
PMID: 38413840
PMC: 11574175.
DOI: 10.1038/s41580-024-00710-6.
African Swine Fever Virus Host-Pathogen Interactions.
Netherton C, Shimmon G, Hui J, Connell S, Reis A
Subcell Biochem. 2023; 106:283-331.
PMID: 38159232
DOI: 10.1007/978-3-031-40086-5_11.
Unravelling the Role of P300 and TMPRSS2 in Prostate Cancer: A Literature Review.
Gioukaki C, Georgiou A, Gkaralea L, Kroupis C, Lazaris A, Alamanis C
Int J Mol Sci. 2023; 24(14).
PMID: 37511059
PMC: 10379122.
DOI: 10.3390/ijms241411299.
Loss of TRIM24 promotes IL-10 expression via CBP/p300-dependent IFNβ1 transcription during macrophage activation.
Hui Z, Fu Y, Chen Y, Yin J, Fang H, Tu Y
Inflamm Res. 2023; 72(7):1441-1452.
PMID: 37326695
DOI: 10.1007/s00011-023-01751-x.
β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer.
Mohan D, Borges K, Finco I, LaPensee C, Rege J, Solon A
Cancer Res. 2023; 83(13):2123-2141.
PMID: 37129912
PMC: 10330305.
DOI: 10.1158/0008-5472.CAN-22-2712.
PGE alters chromatin through H2A.Z-variant enhancer nucleosome modification to promote hematopoietic stem cell fate.
Sporrij A, Choudhuri A, Prasad M, Muhire B, Fast E, Manning M
Proc Natl Acad Sci U S A. 2023; 120(19):e2220613120.
PMID: 37126722
PMC: 10175842.
DOI: 10.1073/pnas.2220613120.
H3.3 contributes to chromatin accessibility and transcription factor binding at promoter-proximal regulatory elements in embryonic stem cells.
Tafessu A, OHara R, Martire S, Dube A, Saha P, Gant V
Genome Biol. 2023; 24(1):25.
PMID: 36782260
PMC: 9926682.
DOI: 10.1186/s13059-023-02867-3.
PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities.
Liu X, Wang A, Shi Y, Dai M, Liu M, Cai H
Molecules. 2023; 28(3).
PMID: 36770884
PMC: 9919707.
DOI: 10.3390/molecules28031217.
Structural insights into p300 regulation and acetylation-dependent genome organisation.
Ibrahim Z, Wang T, Destaing O, Salvi N, Hoghoughi N, Chabert C
Nat Commun. 2022; 13(1):7759.
PMID: 36522330
PMC: 9755262.
DOI: 10.1038/s41467-022-35375-2.
The chromatin remodeling protein ATRX positively regulates IRF3-dependent type I interferon production and interferon-induced gene expression.
Stilp A, Scherer M, Konig P, Furstberger A, Kestler H, Stamminger T
PLoS Pathog. 2022; 18(8):e1010748.
PMID: 35939517
PMC: 9387936.
DOI: 10.1371/journal.ppat.1010748.
The activity of human enhancers is modulated by the splicing of their associated lncRNAs.
Tan J, Marques A
PLoS Comput Biol. 2022; 18(1):e1009722.
PMID: 35015755
PMC: 8803168.
DOI: 10.1371/journal.pcbi.1009722.
Viral Induced Effects on a Vulnerable Epithelium; Lessons Learned From Paediatric Asthma and Eosinophilic Oesophagitis.
Watkinson R, Looi K, Laing I, Cianferoni A, Kicic A
Front Immunol. 2021; 12:773600.
PMID: 34912343
PMC: 8666438.
DOI: 10.3389/fimmu.2021.773600.
No Need to Stick Together to Be Connected: Multiple Types of Enhancers' Networking.
Vitale E, Gugnoni M, Ciarrocchi A
Cancers (Basel). 2021; 13(20).
PMID: 34680347
PMC: 8533737.
DOI: 10.3390/cancers13205201.